Michael Williams
Direktor/Vorstandsmitglied bei Sarcio, Inc.
Profil
Michael Williams is currently a Board Member at Sarcio, Inc. and a Partner at PACE Healthcare Capital.
Previously, he served as a Non-Executive Director at PYC Therapeutics Ltd.
in 2018 and as a Vice President at Bristol Myers Squibb Co. from 2004 to 2005.
He also held positions at Pfizer Inc. as a Vice President and at Intarcia Therapeutics, Inc. as a Chief Operating Officer.
Mr. Williams obtained his undergraduate degree from the University Of Bangor and his graduate degree in 1982 from the same institution.
Aktive Positionen von Michael Williams
| Unternehmen | Position | Beginn |
|---|---|---|
PACE Healthcare Capital
 PACE Healthcare Capital Investment ManagersFinance PACE Healthcare Capital (PACE Healthcare) is a venture capital firm founded in 2020 by Julia Monfrini Peev. The firm is headquartered in Chicago, Illinois. | Berater | - |
Sarcio, Inc.
 Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Sarcio, Inc. develops an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement. The company is based in St. Paul, MN. Sarcio was founded in 2017 by Amanda Vegoe, Beth Lindborg, Timothy D. O’Brien. Beth Lindborg has been the CEO of the company since 2017. | Direktor/Vorstandsmitglied | 01.07.2021 |
Ehemalige bekannte Positionen von Michael Williams
| Unternehmen | Position | Ende |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 11.04.2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Private Equity Investor | 01.01.2005 |
| PFIZER, INC. | Private Equity Investor | - |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Geschäftsführer | - |
Ausbildung von Michael Williams
| University Of Bangor | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| PYC THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
Sarcio, Inc.
Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Sarcio, Inc. develops an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement. The company is based in St. Paul, MN. Sarcio was founded in 2017 by Amanda Vegoe, Beth Lindborg, Timothy D. O’Brien. Beth Lindborg has been the CEO of the company since 2017. | Commercial Services |
PACE Healthcare Capital
PACE Healthcare Capital Investment ManagersFinance PACE Healthcare Capital (PACE Healthcare) is a venture capital firm founded in 2020 by Julia Monfrini Peev. The firm is headquartered in Chicago, Illinois. | Finance |
